基本信息
views: 10
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Our team develops fundamental and translational research focussing on ischaemic disease, diabetes cardiovascular complications, cardiac surgery and cardio-oncology. We aim to decipher the molecular causes of cardiovascular pathologies and to develop novel approaches of cardiovascular protection and repair. Moreover, we investigate new biomarkers to support the development of clinical studies and improve clinical practice.
We are part of local, national and international research networks, including a Leducq Transatlantic Network of Excellence in Vascular miRNAs (MIRVAD https://www.fondationleducq.org/network/microrna-based-therapeutic-strategies-in-vascular-disease-mirvad/ ), the BHF Centre of Regenerative Medicine https://www.cvs.ed.ac.uk/node/1077 an EEU COST action on Cardio RNAs http://www.cost.eu/COST_Actions/ca/CA17129 and a large EEU grant MEDIRAD http://www.medirad-project.eu/ assessing the collateral damage of the impact of low dose radiotherapy.
I have recently transferred my group to Imperial College London from the University of Bristol, where I have maintained open collaborations.
Areas of particular expertise and interests are the following:
Regulatory RNAs
Extracellular vesicles
Therapeutic angiogenesis
Diabetes and Ischaemic disease
We are part of local, national and international research networks, including a Leducq Transatlantic Network of Excellence in Vascular miRNAs (MIRVAD https://www.fondationleducq.org/network/microrna-based-therapeutic-strategies-in-vascular-disease-mirvad/ ), the BHF Centre of Regenerative Medicine https://www.cvs.ed.ac.uk/node/1077 an EEU COST action on Cardio RNAs http://www.cost.eu/COST_Actions/ca/CA17129 and a large EEU grant MEDIRAD http://www.medirad-project.eu/ assessing the collateral damage of the impact of low dose radiotherapy.
I have recently transferred my group to Imperial College London from the University of Bristol, where I have maintained open collaborations.
Areas of particular expertise and interests are the following:
Regulatory RNAs
Extracellular vesicles
Therapeutic angiogenesis
Diabetes and Ischaemic disease
Research Interests
Papers共 426 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Natasha de Winter,Jiahui Ji,Amalia Sintou,Elvira Forte,Michael Lee,Michela Noseda, Aoxue Li,Andrew L. Koenig,Kory Lavine,Sikander Hayat,Nadia Rosenthal,Costanza Emanueli,
Journal of Molecular and Cellular Cardiology (2024): 48-64
EUROPEAN HEART JOURNAL - DIGITAL HEALTHno. 2 (2024): 195-197
Andreia Vilaça,Carlos Jesus,Miguel Lino, Danika Hayman,Costanza Emanueli, Cesare M. Terracciano,Hugo Fernandes,Leon J. de Windt,Lino Ferreira
Molecular Therapy - Nucleic Acidsno. 3 (2024): 102233-102233
Nature communicationsno. 1 (2024): 4259-4259
Nature Reviews Cardiologyno. 8 (2024): 1-18
Soumaya Ben-Aicha,Maryam Anwar, Gemma Vilahur,Fabiana Martino,Panagiotis G. Kyriazis, Natasha de Winter, Prakash P. Punjabi, Gianni D. Angelini,Susanne Sattler,Costanza Emanueli
Molecular Therapy - Nucleic Acidsno. 1 (2024): 102085-102085
L. Nicastro, A. Lal, A. Kyriakou,S. Kholia, R. Nunez Toldra,B. Downing,F. Kermani,M. Anwar, F. Martino, D. Chokron,P. Sarathchandra, M. Sarkar,
medrxiv(2024)
Journal of translational medicineno. 1 (2023): 1-15
Load More
Author Statistics
#Papers: 425
#Citation: 16121
H-Index: 69
G-Index: 115
Sociability: 8
Diversity: 3
Activity: 81
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn